The European Journal of Health Economics

2003 - 2013

Edited by J.-M.G.v.d. Schulenburg

from Springer
Series data maintained by Guenther Eichhorn ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 14, issue 1, 2013

Paying doctors for performance pp. 1-4

Gérard Pouvourville

Is health care a luxury or a necessity or both? Evidence from Turkey pp. 5-10

Nilgun Yavuz, Veli yilanci and Zehra Ozturk

Measuring health outcomes of adolescents: report from a pilot study pp. 11-19

Yemi Oluboyede, Sandy Liane Hélène Tubeuf and Chris McCabe

Federal state differentials in the efficiency of health production in Germany: an artifact of spatial dependence? pp. 21-39

Stefan Felder and Harald Tauchmann

The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007 pp. 41-56

Frank Lichtenberg

Valuing EQ-5D using Time Trade-Off in France pp. 57-66

Julie Chevalier and Gérard Pouvourville

What can we learn from international comparisons of costs by DRG? pp. 67-73

M. Pirson, L. Schenker, D. Martins, Duong Dung, J. Chalé and P. Leclercq

Determinants of household direct and indirect costs: an insight for health-seeking behaviour in Burkina Faso pp. 75-84

Tin Su and Steffen Flessa

A cost-effectiveness analysis of the Incredible Years parenting programme in reducing childhood health inequalities pp. 85-94

Donal O’Neill, Sinéad McGilloway, Michael Donnelly, Tracey Bywater and Paul Kelly

Body weight and health-related quality of life in Catalonia, Spain pp. 95-105

Juan Oliva and Ana Gil-Lacruz

Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall pp. 107-115

E. Wetering, E. Stolk, N. Exel and Werner B.F. Brouwer

Key issues in the design of pay for performance programs pp. 117-131

Frank Eijkenaar

Food prices and overweight patterns in Italy pp. 133-151

Luca Pieroni, D. Lanari and L. Salmasi

Volume 13, issue 6, 2012

The Grossman model after 40 years pp. 677-682

Peter Zweifel

Informal caring-time and caregiver satisfaction pp. 683-705

Miriam Marcén and José Molina

Measuring attitude toward social health insurance pp. 707-722

Chung-Ping Loh, Katrin Nihalani and Oliver Schnusenberg

The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications pp. 723-740

José Rodríguez Barrios, Ferran Pérez Alcántara, Carlos Crespo Palomo, Paloma González García, Enrique Antón De Las Heras and Max Brosa Riestra

Health care usage among immigrants and native-born elderly populations in eleven European countries: results from SHARE pp. 741-754

Aïda Solé-Auró, Montserrat Guillén and Eileen Crimmins

Economic evaluation of pay-for-performance in health care: a systematic review pp. 755-767

Martin Emmert, Frank Eijkenaar, Heike Kemter, Adelheid Esslinger and Oliver Schöffski

Patients whose GP knows complementary medicine tend to have lower costs and live longer pp. 769-776

Peter Kooreman and Erik Baars

Paying informally in the Albanian health care sector: a two-tiered stochastic frontier model pp. 777-788

Sonila Tomini, Wim Groot and Milena Pavlova

The cost-effectiveness of cash versus lottery incentives for a web-based, stated-preference community survey pp. 789-799

Aleksandra Gajic, David Cameron and Jeremiah E. Hurley

Cost effectiveness of golimumab for the treatment of active psoriatic arthritis pp. 801-809

Ewen Cummins, Christian Asseburg, Manishi Prasad, Jacqueline Buchanan and Yogesh Punekar

Favourable cost-benefit in an early defibrillation programme using dual dispatch of ambulance and fire services in out-of-hospital cardiac arrest pp. 811-818

Björn Sund, Leif Svensson, Mårten Rosenqvist and Jacob Hollenberg

Epilepsy in Sweden: health care costs and loss of productivity—a register-based approach pp. 819-826

Kristian Bolin, Anders Lundgren, Fredrik Berggren and Kristina Källén

Volume 13, issue 5, 2012

Health economics and health technology assessment in Central and Eastern Europe: a dose of reality pp. 525-531

L. Gulácsi, E. Orlewska and M. Péntek

Assessing preferences for improved smoking cessation medications: a discrete choice experiment pp. 533-548

Joachim Marti

Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching pp. 549-560

Laura Haas, Tom Stargardt and Jonas Schreyoegg

Disease progression and costs of care in Alzheimer’s disease patients treated with donepezil: a longitudinal naturalistic cohort pp. 561-568

Anders Gustavsson, Linus Jönsson, Johan Parmler, Niels Andreasen, Carina Wattmo, Åsa Wallin and Lennart Minthon

Does participation in clinical trials influence the costs of future management of patients? pp. 569-574

Anne Hvenegaard, Henrik Juhl and Andreas Habicht

Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale pp. 575-587

John Brazier, Donna Rowen, Yaling Yang and Aki Tsuchiya

Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab pp. 589-603

Thomas Delea, Paul Tappenden, Oleg Sofrygin, Dominy Browning, Mayur Amonkar, Jon Karnon, Mel Walker and David Cameron

Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy? pp. 605-614

Juan Oliva

Private health insurance: a role model for European health systems pp. 615-621

Christine Arentz, Johann Eekhoff and Susanna Kochskämper

The sustainability of European health care systems: beyond income and aging pp. 623-634

Fabio Pammolli, Massimo Riccaboni and Laura Magazzini

Medical guidelines, physician density, and quality of care: evidence from German SHARE data pp. 635-649

Hendrik Jürges and Vincent Pohl

Genetic testing in the European Union: does economic evaluation matter? pp. 651-661

Fernando Antoñanzas, R. Rodríguez-Ibeas, M. Hutter, R. Lorente, C. Juárez and M. Pinillos

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country pp. 663-676

Mehlika Toy, Fatih Onder, Ramazan Idilman, Gokhan Kabacam, Jan Richardus, Mithat Bozdayi, Meral Akdogan, Zarife Kuloglu, Aydan Kansu, Solko Schalm and Cihan Yurdaydin

Volume 13, issue 4, 2012

Coping with uncertainty on health decisions: assessing new solutions pp. 375-378

Fernando Antoñanzas, Roberto Rodríguez-Ibeas and Carmelo Juárez-Castelló

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator pp. 379-380

Mattias Neyt and Ann Den Bruel

Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany pp. 381-391

Sarah Dewilde, Bernd Brüggenjürgen, Christoph Nienaber, Jochen Senges, Robert Welte and Stefan Willich

In with the new: the determinants of prescribing innovation by general practitioners in Ireland pp. 393-407

Jane Bourke and Stephen Roper

On the meaningfulness of testing preference axioms in stated preference discrete choice experiments pp. 409-417

Jens Leth Hougaard, Tue Tjur and Lars Østerdal

Factors determining access to and use of primary health care services in the Girona Health Region (Spain) pp. 419-427

Carme Saurina, Laura Vall-llosera and Marc Saez

Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease pp. 429-443

Paddy Gillespie, Eamon O’Shea, Andrew Murphy, Susan Smith, Mary Byrne, Molly Byrne and Margaret Cupples

Cost–effectiveness of statins revisited: lessons learned about the value of innovation pp. 445-450

Peter Lindgren and Bengt Jönsson

The effect of health shocks on smoking and obesity pp. 451-460

Leonie Sundmacher

The trade-off between formal and informal care in Spain pp. 461-490

Sergi Jimenez-Martin and Cristina Prieto

The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design pp. 491-500

Arthur Ewoud Attema and Werner B.F. Brouwer

A proposed model for economic evaluations of major depressive disorder pp. 501-510

Hossein Haji Ali Afzali, Jonathan Karnon and Jodi Gray

Cost of care for colorectal cancer in Ireland: a health care payer perspective pp. 511-524

L. Tilson, L. Sharp, C. Usher, C. Walsh, S Whyte, A. O’Ceilleachair, C. Stuart, B. Mehigan, M. John Kennedy, P. Tappenden, J. Chilcott, Anthony Staines, H. Comber and M. Barry

Volume 13, issue 3, 2012

Time to incorporate time in cost-effectiveness analysis pp. 223-226

Gijs Wetering, Willem Woertman and Eddy Adang

Smoking bans and the secondhand smoking problem: an economic analysis pp. 227-236

Annette Hofmann and Martin Nell

Incremental net benefit and acceptability of alternative health policies: a case study of mass screening for colorectal cancer pp. 237-250

Pauline Chauvin, Jean-Michel Josselin and Denis Heresbach

I feel good! Gender differences and reporting heterogeneity in self-assessed health pp. 251-265

Udo Schneider, Christian Pfarr, Brit Schneider and Volker Ulrich

Socioeconomic analysis of patient-centric networks: effects of patients and hospitals’ characteristics and network structure on hospitalization costs pp. 267-276

Alireza Abbasi, Shahadat Uddin and Liaquat Hossain

The demand for sports and exercise: results from an illustrative survey pp. 277-287

Nana Anokye, Subhash Pokhrel, Martin Buxton and Julia Fox-Rushby

Cancer patients’ willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network pp. 289-300

Nathalie Havet, Magali Morelle, Raphaël Remonnay and Marie-Odile Carrere

Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data pp. 301-313

Maria-Isabel Farfan-Portet, Carine Van de Voorde, France Vrijens and Robert Vander Stichele

Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data pp. 315-325

France Vrijens, Carine Van de Voorde, Maria-Isabel Farfan-Portet and Robert Vander Stichele

Formal and informal care for disabled elderly living in the community: an appraisal of French care composition and costs pp. 327-336

Alain Paraponaris, Bérengère Davin and Pierre Verger

Impact of healthcare reforms on out-of-pocket health expenditures in Turkey for public insurees pp. 337-346

Burcay Erus and Nazli Aktakke

Lifetime costs of the top five cancers in Taiwan pp. 347-353

Hui-Chu Lang and Shi-Liang Wu

Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis pp. 355-363

Lone Baandrup, Jan Sørensen, Henrik Lublin, Merete Nordentoft and Birte Glenthoj

Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany pp. 365-374

Galin Michailov, Glenn Davies and Karl Krobot

Volume 13, issue 2, 2012

Separating the wheat from the chaff pp. 121-126

Claus Runge

Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis pp. 127-144

Mareike Schad and Juergen John

Cost-effectiveness of treatment with etanercept for psoriasis in Sweden pp. 145-156

Christopher Knight, Josephine Mauskopf, Mats Ekelund, Amitabh Singh, Shiyi Yang and Robert Boggs

Malpractice liability, technology choice and negative defensive medicine pp. 157-167

Eberhard Feess

Decision-making in general practice: the effect of financial incentives on the use of laboratory analyses pp. 169-180

Siri Munkerud

Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam pp. 181-192

Steven Edwards, Sarah Wordsworth and Mike Clarke

Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidence pp. 193-202

Oliver Reich, Cornelia Weins, Claudia Schusterschitz and Magdalena Thöni

Defining care products to finance health care in the Netherlands pp. 203-221

Machiel Westerdijk, Joost Zuurbier, Martijn Ludwig and Sarah Prins

Volume 13, issue 1, 2012

Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe? pp. 1-5

Michael Drummond and Adrian Towse

The convergence of health care financing structures: empirical evidence from OECD-countries pp. 7-18

Andrea M. Leiter and Engelbert Theurl

Decomposing the determinants of health care expenditure: the case of Spain pp. 19-27

David Prieto and Santiago Lago-Peñas

The impact of presumed consent laws and institutions on deceased organ donation pp. 29-38

Firat Bilgel

The impact of BMI on direct costs in Children and Adolescents: empirical findings for the German Healthcare System based on the KiGGS-study pp. 39-50

Christina Wenig

Spillover effects of supplementary on basic health insurance: evidence from the Netherlands pp. 51-62

Anne-Fleur Roos and Frederik Schut

Future costs in cost-effectiveness analysis: an empirical assessment pp. 63-70

Marie Kruse, Jan Sørensen and Dorte Gyrd-Hansen

Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy pp. 71-80

O. Zaniolo, S. Iannazzo, L. Pradelli and M. Miravitlles

The cost of multiple sclerosis in Norway pp. 81-91

B. Svendsen, K.-M. Myhr, H. Nyland and J. Aarseth

Do smoke-free laws affect revenues in pubs and restaurants? pp. 93-99

Hans Olav Melberg and Karl Lund

Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands pp. 101-110

I. Lenoir-Wijnkoop, W. Aalderen, G. Boehm, D. Klaassen, A. Sprikkelman and M. Nuijten

Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications pp. 111-120

Nick Kontodimopoulos, Evelina Pappa, Zinovia Chadjiapostolou, Eleni Arvanitaki, Angelos Papadopoulos and Dimitris Niakas